Nalbuphine as an Adjuvant to Intravenous Regional Anesthesia

• Status: Completed
• Trial end date: 2016-03-01
• Target enrollment: 0
• Participant gender: All

Summary

The effect of addition of nalbuphine to lidocaine in intravenous regional anesthesia

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Assiut University
• Treatments: Lidocaine; Nalbuphine

Criteria

Inclusion Criteria:

• adult patients

• American Society of Anesthesiologists (ASA) physical status I-II

• age between 20 and 50 years old

• scheduled for elective unilateral short hand surgery

Exclusion Criteria:

• allergy to study medications

• body mass index > 35 kg/m2

• patients with sickle cell disease or Reynaud disease

• patient refusal